Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia - PubMed (original) (raw)
Randomized Controlled Trial
. 2011 Oct;8(10):2883-93.
doi: 10.1111/j.1743-6109.2011.02414.x. Epub 2011 Aug 2.
Affiliations
- PMID: 21810191
- DOI: 10.1111/j.1743-6109.2011.02414.x
Randomized Controlled Trial
Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia
Chi-Fai Ng et al. J Sex Med. 2011 Oct.
Abstract
Introduction: Dyslipidemia is closely related to erectile dysfunction (ED). Evidence has shown that the lipid-lowering agent, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (statins), can improve erectile function. However, information about the potential role of another class of lipid-lowering agent, niacin, is unknown.
Aim: To assess the effect of niacin alone on erectile function in patients suffering from both ED and dyslipidemia.
Methods: A single center prospective randomized placebo-controlled parallel-group trial was conducted. One hundred sixty male patients with ED and dyslipidemia were randomized in a one-to-one ratio to receive up to 1,500 mg oral niacin daily or placebo for 12 weeks.
Main outcome measures: The primary outcome measure was the improvement in erectile function as assessed by question 3 and question 4 of the International Index of Erectile Function (IIEF Q3 and Q4). Secondary outcome measurements included the total IIEF score, IIEF-erectile function domain, and Sexual Health Inventory for Men (SHIM) score.
Results: From the overall analysis, the niacin group showed a significant increase in both IIEF-Q3 scores (0.53 ± 1.18, P < 0.001) and IIEF-Q4 scores (0.35 ± 1.17, P = 0.013) compared with baseline values. The placebo group also showed a significant increase in IIEF-Q3 scores (0.30 ± 1.16, P = 0.040) but not IIEF-Q4 scores (0.24 ± 1.13, P = 0.084). However, when patients were stratified according to the baseline severity of ED, the patients with moderate and severe ED who received niacin showed a significant improvement in IIEF-Q3 scores (0.56 ± 0.96 [P = 0.037] and 1.03 ± 1.20 [P < 0.001], respectively) and IIEF-Q4 scores (0.56 ± 1.03 [P = 0.048] and 0.84 ± 1.05 [P < 0.001], respectively] compared with baseline values, but not for the placebo group. The improvement in IIEF-EF domain score for severe and moderate ED patients in the niacin group were 5.28 ± 5.94 (P < 0.001) and 3.31 ± 4.54 (P = 0.014) and in the placebo group were 2.65 ± 5.63 (P < 0.041) and 2.74 ± 5.59 (P = 0.027), respectively. There was no significant improvement in erectile function for patients with mild and mild-to-moderate ED for both groups. For patients not receiving statins treatment, there was a significant improvement in IIEF-Q3 scores (0.47 ± 1.16 [P = 0.004]) for the niacin group, but not for the placebo group.
Conclusions: Niacin alone can improve the erectile function in patients suffering from moderate to severe ED and dyslipidemia.
© 2011 International Society for Sexual Medicine.
Similar articles
- Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V. Skoumal R, et al. Eur Urol. 2004 Sep;46(3):362-9; discussion 369. doi: 10.1016/j.eururo.2004.04.026. Eur Urol. 2004. PMID: 15306109 Clinical Trial. - Efficacy and safety of mirodenafil in men taking antihypertensive medications.
Paick JS, Kim JJ, Kim SC, Moon KH, Min KS, Park K, Suh JK, Yang DY. Paick JS, et al. J Sex Med. 2010 Sep;7(9):3143-52. doi: 10.1111/j.1743-6109.2010.01926.x. J Sex Med. 2010. PMID: 20649936 Clinical Trial. - Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A. Eardley I, et al. BJU Int. 2004 Oct;94(6):871-7. doi: 10.1111/j.1464-410X.2004.05049.x. BJU Int. 2004. PMID: 15476525 Clinical Trial. - Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.
Mulhall JP, Levine LA, Jünemann KP. Mulhall JP, et al. Urology. 2006 Sep;68(3 Suppl):17-25. doi: 10.1016/j.urology.2006.05.041. Urology. 2006. PMID: 17011372 Review.
Cited by
- Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis.
Zhong O, Wang J, Tan Y, Lei X, Tang Z. Zhong O, et al. Nutr Metab (Lond). 2022 Mar 18;19(1):20. doi: 10.1186/s12986-022-00653-9. Nutr Metab (Lond). 2022. PMID: 35303905 Free PMC article. - The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS).
Calogero AE, Aversa A, La Vignera S, Corona G, Ferlin A. Calogero AE, et al. J Endocrinol Invest. 2017 Dec;40(12):1389-1397. doi: 10.1007/s40618-017-0699-6. Epub 2017 Jun 6. J Endocrinol Invest. 2017. PMID: 28589384 No abstract available. - Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial.
Abedi P, Najafian M, Yaralizadeh M, Namjoyan F. Abedi P, et al. J Med Life. 2018 Jan-Mar;11(1):24-28. J Med Life. 2018. PMID: 29696061 Free PMC article. Clinical Trial. - Commentary on "Relationship between dietary niacin intake and erectile dysfunction: a population-based study".
Chung E. Chung E. Asian J Androl. 2024 Jul 1;26(4):439. doi: 10.4103/aja202424. Epub 2024 Apr 26. Asian J Androl. 2024. PMID: 38727255 Free PMC article. No abstract available. - Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemia.
Hu M, Yang YL, Ng CF, Lee CP, Lee VWY, Hanada H, Masuda D, Yamashita S, Tomlinson B. Hu M, et al. Medicine (Baltimore). 2015 May;94(20):e881. doi: 10.1097/MD.0000000000000881. Medicine (Baltimore). 2015. PMID: 25997070 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical